how long until retatrutide is fda approved Approval Status 2026: Everything We Know So Far Retatrutide for Weight Loss: TRIUMPH-1

Byetta (exenatide immediate-release) Summary of Product Characteristics

The promise of a weekly skin patch for weight loss sounds revolutionary, yet the science behind GLP-1 delivery methods tells a different story in 2026

I will tell you, in the phase three trials, anywhere from 8 to 15% of individuals in the trials so we know they're taking the drug do not lose at least 5% of their body weight

And that conversation is only just beginning.

Assays for sulfonylureas should also be obtained to rule out iatrogenic hypoglycemia, along with an elevated C-peptide level, especially in patients with previous or current diabetes mellitus

Most people find that these symptoms disappear after the first one to two weeks of consistent use